Cognition Therapeutics Inc financial data

Symbol
CGTX on Nasdaq
Location
2403 Sidney Street, Suite 261, Pittsburgh, PA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 6, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 278 % -9.15%
Debt-to-equity 56.6 % +13.8%
Return On Equity -150 % +0.54%
Return On Assets -95.9 % +4.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 88.3M shares +112%
Common Stock, Shares, Outstanding 88.3M shares +116%
Entity Public Float 56.3M USD +30.6%
Common Stock, Value, Issued 88K USD +115%
Weighted Average Number of Shares Outstanding, Basic 78M shares +92.9%
Weighted Average Number of Shares Outstanding, Diluted 78M shares +92.9%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 34.2M USD -24.2%
General and Administrative Expense 10.7M USD -19.9%
Operating Income (Loss) -44.9M USD +23.2%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -4.73M USD +19.6%
Net Income (Loss) Attributable to Parent -28M USD +18.3%
Earnings Per Share, Basic 0 USD/shares +51.5%
Earnings Per Share, Diluted 0 USD/shares +51.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 39.3M USD +78.7%
Assets, Current 42.9M USD +59.8%
Property, Plant and Equipment, Net 159K USD -23.2%
Operating Lease, Right-of-Use Asset 353K USD -34.9%
Assets 43.4M USD +57.3%
Accounts Payable, Current 827K USD -56.4%
Employee-related Liabilities, Current 1.3M USD -12.4%
Accrued Liabilities, Current 3.92M USD -58.7%
Liabilities, Current 6.65M USD -47.6%
Deferred Income Tax Liabilities, Net 110K USD -25.2%
Operating Lease, Liability, Noncurrent 212K USD -45.9%
Other Liabilities, Noncurrent 0 USD
Liabilities 6.87M USD -47.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax -195K USD +2.01%
Retained Earnings (Accumulated Deficit) -195M USD -16.7%
Stockholders' Equity Attributable to Parent 36.5M USD +152%
Liabilities and Equity 43.4M USD +57.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -9.88M USD -36.3%
Net Cash Provided by (Used in) Financing Activities 1.3M USD -89.2%
Net Cash Provided by (Used in) Investing Activities -41K USD +69.4%
Common Stock, Shares Authorized 250M shares 0%
Common Stock, Shares, Issued 88.3M shares +116%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -8.58M USD -281%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 39.8M USD +80.9%
Deferred Tax Assets, Valuation Allowance 29.4M USD +32.4%
Deferred Tax Assets, Gross 29.5M USD +32%
Operating Lease, Liability 380K USD -34.5%
Payments to Acquire Property, Plant, and Equipment 41K USD -69.4%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -28M USD +17.9%
Lessee, Operating Lease, Liability, to be Paid 424K USD -36%
Property, Plant and Equipment, Gross 1.34M USD +0.3%
Operating Lease, Liability, Current 168K USD -10.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 87K USD -44.9%
Lessee, Operating Lease, Liability, to be Paid, Year One 155K USD -31.4%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 44K USD -46.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 88K USD -3.3%
Deferred Tax Assets, Operating Loss Carryforwards 8.49M USD +24%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 38K USD -58.7%
Operating Lease, Payments 56K USD 0%
Additional Paid in Capital 232M USD +27.5%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 27K USD +28.6%
Deferred Tax Assets, Net of Valuation Allowance 110K USD -25.2%
Share-based Payment Arrangement, Expense 2.26M USD -47.2%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%